News
KNTPF
0.170
NaN%
--
Weekly Report: what happened at KNTPF last week (0415-0419)?
Weekly Report · 6d ago
Weekly Report: what happened at KNTPF last week (0408-0412)?
Weekly Report · 04/15 10:10
Weekly Report: what happened at KNTPF last week (0401-0405)?
Weekly Report · 04/08 10:12
Weekly Report: what happened at KNTPF last week (0325-0329)?
Weekly Report · 04/01 10:12
Weekly Report: what happened at KNTPF last week (0318-0322)?
Weekly Report · 03/25 10:13
Weekly Report: what happened at KNTPF last week (0311-0315)?
Weekly Report · 03/18 10:12
Weekly Report: what happened at KNTPF last week (0304-0308)?
Weekly Report · 03/11 10:11
Weekly Report: what happened at KNTPF last week (0226-0301)?
Weekly Report · 03/04 10:12
Weekly Report: what happened at KNTPF last week (0219-0223)?
Weekly Report · 02/26 10:20
Weekly Report: what happened at KNTPF last week (0212-0216)?
Weekly Report · 02/19 10:20
Weekly Report: what happened at KNTPF last week (0205-0209)?
Weekly Report · 02/12 10:14
Weekly Report: what happened at KNTPF last week (0129-0202)?
Weekly Report · 02/05 10:19
Weekly Report: what happened at KNTPF last week (0122-0126)?
Weekly Report · 01/29 10:13
Weekly Report: what happened at KNTPF last week (0115-0119)?
Weekly Report · 01/22 10:15
Weekly Report: what happened at KNTPF last week (0108-0112)?
Weekly Report · 01/15 10:13
Weekly Report: what happened at KNTPF last week (0101-0105)?
Weekly Report · 01/08 10:15
Weekly Report: what happened at KNTPF last week (1225-1229)?
Weekly Report · 01/01 10:12
Weekly Report: what happened at KNTPF last week (1218-1222)?
Weekly Report · 12/25/2023 10:19
Weekly Report: what happened at KNTPF last week (1211-1215)?
Weekly Report · 12/18/2023 10:22
Weekly Report: what happened at KNTPF last week (1204-1208)?
Weekly Report · 12/11/2023 10:19
More
Webull provides a variety of real-time KNTPF stock news. You can receive the latest news about Kintor Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About KNTPF
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China. The Company is focused on the research and development of drugs for cancers and other androgen receptor (AR) related diseases. Its primary drug candidate is Proxalutamide which is in phase III clinical trials in China for metastatic castration-resistant prostate cancer (mCRPC). The Company are also developing other drug candidates, including a phase II small molecule drug candidate Pyrilutamide, a phase II monoclonal antibody drug candidate ALK-1, a phase I mTOR inhibitor drug candidate Detorsertib and an inhibitor of the hedgehog signal translation pathway GT1708F.